SCHEMBL6928663

SCHEMBL6928663

O=Cc1cc(F)ccc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.52
CES2 O00748 2/20 0.47
CES1 P23141 2/20 0.47
BCL2L1 Q07817 1/20 0.45
BAD Q92934 1/20 0.45
ERN1 O75460 2/20 0.44
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
DHFR P00374 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
LMNA P02545 1/20 0.41
TTR P02766 1/20 0.41
ALB P02768 1/20 0.41
HMGB1 P09429 1/20 0.41
HPGD P15428 1/20 0.41
CXCL12 P48061 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29952055 0.86 KEAP1 (0.55) KEAP1CES2CES1ERN1ALDH1A1
SCHEMBL9983741 0.86 KEAP1 (0.55) KEAP1CES2CES1ERN1ALDH1A1
SCHEMBL8815443 0.82 KEAP1 (0.50) KEAP1CES2CES1BCL2L1BAD
SCHEMBL5087817 0.82 CES2 (0.45) KEAP1CES2CES1ERN1ALDH1A1
SCHEMBL15331324 0.79 ERN1 (0.43) KEAP1BCL2L1BADERN1KDM4E
SCHEMBL1302677 0.79 ERN1 (0.49) ERN1ALDH1A1KDM4EMEN1CA1
SCHEMBL436346 0.79 ALDH1A1 (0.48) ERN1ALDH1A1KDM4ECA1CA2
SCHEMBL3388426 0.79 CA12 (0.57) KEAP1CES2ERN1ALDH1A1MEN1
SCHEMBL30014296 0.79 ALDH1A1 (0.48) ERN1ALDH1A1KDM4ECA1CA2
SCHEMBL30253662 0.79 ERN1 (0.49) ERN1ALDH1A1KDM4EMEN1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114853783-B Imidazo [4,5-e ] thiophene [2,3-b ] pyridoindolone compound and preparation method and application thereof 中山大学 2023-05-12 CN claimed
CN-114853783-A Imidazole [4,5-e ] thiophene [2,3-b ] pyridoindolone compounds and preparation method and application thereof 中山大学 2022-08-05 CN claimed
CN-109134410-B Synthesis method of 5-fluoro-3-methylisobenzofuran-1 (3H) -ketone 沈阳药科大学 2022-03-25 CN claimed
CN-113603661-A Synthesis method of (S) -5-fluoro-3-methylisobenzofuran-3-one 沈阳药科大学 2021-11-05 CN claimed
US-20260035354-A1 PIPERIDINEDIONE DERIVATIVES INNOCURE THERAPEUTICS, INC. (KR) 2026-02-05 US disclosed
EP-4640686-A1 DEGRADER FOR DEGRADING BRD PROTEIN AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Innocure Therapeutics, Inc. (KR) 2025-10-29 EP disclosed
EP-4624466-A1 DEGRADER FOR DECOMPOSING CMET PROTEIN, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Innocure Therapeutics, Inc. (KR) 2025-10-01 EP disclosed
EP-4624472-A1 DEGRADER INCLUDING NOVEL C-MET PROTEIN LIGAND AND PHARMACEUTICAL COMPOSITION INCLUDING SAME Innocure Therapeutics, Inc. (KR) 2025-10-01 EP disclosed
US-12384756-B2 Piperidinedione derivatives INNOCURE THERAPEUTICS, INC. (KR) 2025-08-12 US disclosed
CN-120157657-A Phthalazinone compound containing piperazinone, preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2025-06-17 CN disclosed
WO-2024112122-A1 DEGRADER FOR DEGRADING BRD PROTEIN AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 주식회사 이노큐어테라퓨틱스 2024-05-30 WO disclosed
WO-2024112120-A1 DEGRADER INCLUDING NOVEL C-MET PROTEIN LIGAND AND PHARMACEUTICAL COMPOSITION INCLUDING SAME 주식회사 이노큐어테라퓨틱스 2024-05-30 WO disclosed
EP-2632915-B1 BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INT (DE) 2015-08-12 EP disclosed
US-8829200-B2 Benzimidazole inhibitors of leukotriene production BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-09-09 US disclosed
US-8829200-B2 Benzimidazole inhibitors of leukotriene production BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-09-09 US disclosed
US-20120277226-A1 BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-11-01 US disclosed
US-20120277226-A1 BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-11-01 US disclosed
WO-2012058254-A1 BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-03 WO disclosed
WO-2011109551-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-09-09 WO disclosed
US-4620867-A 1-carbalkoxyalkyl-3-aryloxy-4-(substituted-2'-carboxyphenyl)-azet-2-ones as plant growth regulators and herbicides CHEVRON RESEARCH COMPANY (US) 1986-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035354-A1 PIPERIDINEDIONE DERIVATIVES CRBN, PSMC1, PSME3 KEAP1 643/4885CES2 4192/4885CES1 3038/4885
US-20120277226-A1 BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION LTB4R, LTB4R2, LTC4S KEAP1 905/4885CES2 1544/4885CES1 95/4885
US-12384756-B2 Piperidinedione derivatives CRBN, CUL1, PSMB10 KEAP1 706/4885CES2 4811/4885CES1 4032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.